Amphora® completed a phase III contraceptive clinical trial.

Read More


Amphora® offers potential applications for women all over the world.

Read More


Evofem is committed
to giving women access to better healthcare options.

Read More

Empower Women logo_vChange the World

Evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. Women need access to effective products that are well suited to their lifestyle and consistent with their core values.

Latest News


Evofem Files IND for Evaluation of Prevention of Recurrence of Bacterial Vaginosis

March 31, 2016

  SAN DIEGO – March 31, 2016 — Evofem, a biotechnology company focused on the development and commercialization of women’s health products, announced today that it filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) requesting clearance to begin human clinical trials for its lead product in development, a…

More News